NORTHWEST BIOTHERAPEUTICS INC - COM (NWBO) Institutional Ownership

CUSIP: 66737P600

13F Institutional Holders and Ownership History from Q1 2014 to Q4 2025

Type / Class
Equity / COM
Symbol
NWBO on OTC
Price per share
$0.23
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
206,344
Total reported value
$43,661
% of total 13F portfolios
0%
Share change
+8,000
Value change
+$1,076
Number of holders
5
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Investment Quick Answers

What is CUSIP 66737P600?
CUSIP 66737P600 identifies NWBO - NORTHWEST BIOTHERAPEUTICS INC - COM in SEC 13F datasets.

Where can I see the latest institutional holders?
Review the Q4 2025 holders report and the ownership history table below.

As of 31 Dec 2025, 5 institutional investors reported holding 206,344 shares of NORTHWEST BIOTHERAPEUTICS INC - COM (NWBO).

Institutional Holders of NORTHWEST BIOTHERAPEUTICS INC - COM (NWBO) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 206,344 $43,661 +$1,076 $0.23 5
2025 Q3 733,054 $175,164 +$2,270 $0.24 7
2025 Q2 723,604 $173,524 +$6,853 $0.24 7
2025 Q1 696,814 $160,167 -$902 $0.23 7
2024 Q4 712,146 $196,441 -$3,821 $0.27 9
2024 Q3 655,342 $208,709 -$10,242 $0.32 9
2024 Q2 669,855 $286,210 +$26,792 $0.43 11
2024 Q1 587,080 $303,577 +$45,331 $0.52 8
2023 Q4 521,164 $365,079 -$9,144 $0.70 8
2023 Q3 529,671 $481,940 +$20,923 $0.91 9
2023 Q2 2,976,111 $1,689,679 -$167,500 $0.57 10
2023 Q1 3,214,516 $2,009,124 +$254,851 $0.62 13
2022 Q4 2,817,706 $2,249,392 +$538,509 $0.78 14
2022 Q3 2,147,761 $1,697,062 -$31,707 $0.71 12
2022 Q2 1,002,870 $633,114 +$85,411 $0.63 13
2022 Q1 867,691 $602,962 +$29,682 $0.70 14
2021 Q4 824,457 $576,000 +$65,002 $0.70 12
2021 Q3 353,257 $452,000 -$58,919 $1.28 9
2021 Q2 392,657 $576,000 +$113,446 $1.46 12
2021 Q1 315,480 $471,000 +$69,236 $1.49 9
2020 Q4 269,242 $409,000 +$182,583 $1.51 8
2020 Q3 149,062 $114,000 +$26,394 $0.76 5
2020 Q2 114,162 $39,000 -$16,656 $0.34 5
2020 Q1 224,503 $36,000 +$21,000 $0.16 6
2019 Q4 92,500 $20,000 -$1,000 $0.21 4
2019 Q3 98,500 $23,000 -$29,000 $0.24 5
2019 Q2 158,500 $42,000 +$4,333 $0.26 6
2019 Q1 142,700 $39,000 -$2,980 $0.27 5
2018 Q4 166,950 $34,000 +$9,000 $0.20 6
2018 Q3 122,500 $23,000 +$2,000 $0.19 4
2018 Q2 112,500 $29,000 $0.26 4
2018 Q1 112,500 $29,000 +$15,667 $0.26 4
2017 Q4 52,500 $13,000 $0.25 3
2017 Q3 52,500 $10,000 +$6,000 $0.20 3
2017 Q2 24,650 $4,000 -$24,000 $0.16 2
2017 Q1 120,367 $29,000 -$8,796,000 $0.24 4
2016 Q4 25,376,730 $8,833,000 -$4,250,328 $0.35 7
2016 Q3 33,581,674 $18,228,000 -$1,830,308 $0.54 43
2016 Q2 36,749,642 $21,417,000 -$4,259,609 $0.58 54
2016 Q1 42,063,772 $61,468,000 +$4,175,990 $1.46 70
2015 Q4 38,793,496 $124,135,091 +$15,720,747 $3.20 75
2015 Q3 33,696,688 $210,635,694 +$25,114,864 $6.25 75
2015 Q2 29,325,405 $291,015,053 +$117,189,562 $9.93 80
2015 Q1 17,517,073 $129,085,755 +$22,424,604 $7.37 71
2014 Q4 14,594,118 $78,077,182 -$3,769,823 $5.35 65
2014 Q3 8,642,567 $43,461,630 +$530,523 $5.03 66
2014 Q2 8,400,646 $56,345,755 +$7,484,876 $6.71 76
2014 Q1 7,248,611 $52,465,344 +$8,479,500 $7.24 55